日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/17 | 3,969 | 4,007 | 3,969 | 4,000 | +34 | +0.9% | 108,500 |
| 2025/03/14 | 3,971 | 4,000 | 3,942 | 3,966 | -25 | -0.6% | 204,100 |
| 2025/03/13 | 3,999 | 4,054 | 3,969 | 3,991 | -14 | -0.3% | 164,200 |
| 2025/03/12 | 3,895 | 4,023 | 3,894 | 4,005 | +58 | +1.5% | 212,900 |
| 2025/03/11 | 3,946 | 3,974 | 3,858 | 3,947 | -39 | -1% | 304,900 |
| 2025/03/10 | 4,010 | 4,032 | 3,958 | 3,986 | -8 | -0.2% | 170,800 |
| 2025/03/07 | 3,985 | 3,996 | 3,951 | 3,994 | -16 | -0.4% | 183,500 |
| 2025/03/06 | 4,000 | 4,058 | 3,986 | 4,010 | +6 | +0.1% | 178,700 |
| 2025/03/05 | 4,096 | 4,096 | 3,993 | 4,004 | -72 | -1.8% | 259,600 |
| 2025/03/04 | 4,119 | 4,182 | 4,060 | 4,076 | -3 | -0.1% | 384,800 |
| 2025/03/03 | 3,985 | 4,096 | 3,949 | 4,079 | +141 | +3.6% | 340,400 |
| 2025/02/28 | 3,929 | 4,011 | 3,929 | 3,938 | +11 | +0.3% | 332,500 |
| 2025/02/27 | 3,919 | 3,951 | 3,893 | 3,927 | -2 | -0.1% | 236,300 |
| 2025/02/26 | 4,001 | 4,020 | 3,881 | 3,929 | -76 | -1.9% | 274,600 |
| 2025/02/25 | 3,873 | 4,023 | 3,872 | 4,005 | +132 | +3.4% | 372,500 |
| 2025/02/21 | 3,876 | 3,908 | 3,856 | 3,873 | +22 | +0.6% | 160,500 |
| 2025/02/20 | 3,905 | 3,942 | 3,830 | 3,851 | -64 | -1.6% | 172,300 |
| 2025/02/19 | 3,930 | 3,959 | 3,906 | 3,915 | -16 | -0.4% | 193,100 |
| 2025/02/18 | 3,890 | 3,957 | 3,890 | 3,931 | +25 | +0.6% | 139,700 |
| 2025/02/17 | 4,009 | 4,014 | 3,894 | 3,906 | -122 | -3% | 258,200 |
| 2025/02/14 | 3,920 | 4,028 | 3,900 | 4,028 | +66 | +1.7% | 277,900 |
| 2025/02/13 | 3,915 | 3,980 | 3,891 | 3,962 | +74 | +1.9% | 231,700 |
| 2025/02/12 | 3,934 | 3,983 | 3,864 | 3,888 | -70 | -1.8% | 357,600 |
| 2025/02/10 | 4,000 | 4,053 | 3,871 | 3,958 | +61 | +1.6% | 496,600 |
| 2025/02/07 | 3,882 | 4,016 | 3,868 | 3,897 | -3 | -0.1% | 341,900 |
| 2025/02/06 | 3,889 | 3,914 | 3,861 | 3,900 | +47 | +1.2% | 182,600 |
| 2025/02/05 | 3,800 | 3,873 | 3,787 | 3,853 | +39 | +1% | 191,500 |
| 2025/02/04 | 3,775 | 3,879 | 3,759 | 3,814 | +125 | +3.4% | 358,400 |
| 2025/02/03 | 3,759 | 3,775 | 3,640 | 3,689 | -76 | -2% | 372,400 |
| 2025/01/31 | 3,773 | 3,777 | 3,737 | 3,765 | -7 | -0.2% | 241,200 |
| 2025/01/30 | 3,705 | 3,795 | 3,705 | 3,772 | +72 | +1.9% | 286,600 |
| 2025/01/29 | 3,730 | 3,740 | 3,669 | 3,700 | -41 | -1.1% | 328,100 |
| 2025/01/28 | 3,808 | 3,832 | 3,727 | 3,741 | -54 | -1.4% | 266,000 |
| 2025/01/27 | 3,807 | 3,826 | 3,779 | 3,795 | +4 | +0.1% | 192,800 |
| 2025/01/24 | 3,762 | 3,857 | 3,762 | 3,791 | +22 | +0.6% | 275,100 |
| 2025/01/23 | 3,729 | 3,803 | 3,729 | 3,769 | +6 | +0.2% | 254,900 |
| 2025/01/22 | 3,769 | 3,789 | 3,749 | 3,763 | +15 | +0.4% | 161,300 |
| 2025/01/21 | 3,704 | 3,754 | 3,701 | 3,748 | +11 | +0.3% | 157,700 |
| 2025/01/20 | 3,701 | 3,771 | 3,700 | 3,737 | +30 | +0.8% | 211,600 |
| 2025/01/17 | 3,800 | 3,816 | 3,706 | 3,707 | -113 | -3% | 197,100 |
| 2025/01/16 | 3,834 | 3,864 | 3,820 | 3,820 | +1 | ±0% | 168,600 |
| 2025/01/15 | 3,850 | 3,888 | 3,780 | 3,819 | -58 | -1.5% | 241,300 |
| 2025/01/14 | 3,930 | 3,968 | 3,866 | 3,877 | -81 | -2% | 283,200 |
| 2025/01/10 | 3,980 | 3,994 | 3,941 | 3,958 | -41 | -1% | 188,800 |
| 2025/01/09 | 4,018 | 4,051 | 3,945 | 3,999 | -11 | -0.3% | 223,300 |
| 2025/01/08 | 4,047 | 4,074 | 4,010 | 4,010 | -42 | -1% | 198,400 |
| 2025/01/07 | 4,055 | 4,095 | 4,028 | 4,052 | +16 | +0.4% | 363,200 |
| 2025/01/06 | 3,997 | 4,088 | 3,961 | 4,036 | +47 | +1.2% | 293,900 |
| 2024/12/30 | 3,987 | 4,006 | 3,963 | 3,989 | -18 | -0.4% | 187,800 |
| 2024/12/27 | 3,970 | 4,015 | 3,960 | 4,007 | +76 | +1.9% | 287,600 |
51～
100
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 356,100円 | +8.0% | -15.3% | 3.48% | 10.00倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 76,000円 | -11.0% | +206.6% | 0.00% | 7.55倍 | 1.78倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 341,300円 | +3.8% | -19.9% | 3.98% | 11.16倍 | 0.85倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 175,400円 | +5.0% | +1.5% | 0.00% | 15.00倍 | 3.99倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 301,500円 | - | - | 0.00% | - | 139.65倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
